A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis
for Systemic Sclerosis (SSc)
9 locations incl. Phoenix
Sponsor: argenx
Sex: All·Age: 18+
Code: NCT06655155·Phase 2·Recruiting·Listed Oct 2024
Thomas Jefferson University
Clinical research site in Columbia, Maryland
Part of Thomas Jefferson University
As of July 2026, 1 paid clinical trial is recruiting at Thomas Jefferson University in Columbia, Maryland. Active studies at this site focus on Systemic Sclerosis (SSc) alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Thomas Jefferson University (1)
More research sites in Columbia
- Central Maryland Radiation Oncology in Howard County (7 trials)
- Centennial Medical Group (6 trials)
- Central Maryland Radiation Oncology (5 trials)
- Maryland Oncology Hematology, P.A. (5 trials)
- Johns Hopkins University (4 trials)
- Maryland Oncology Hematology (4 trials)
- MedStar Health Research Institute (3 trials)
- Central Maryland Oncology Center (2 trials)
- Erlanger Health System (2 trials)
- Kailera Clinical Site (2 trials)
Explore more
Paid clinical trials in Columbia, MD · Maryland clinical trials